Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, announced today that Federico Tripodi, Chief Executive Officer, will present at the Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26 at 10:30 a.m. Eastern Time in New York, NY.
A live webcast will be available at http://wsw.com/webcast/ladenburg3/clxt/.
The replay will be available in the Events section of the Company’s website at http://www.calyxt.com/newsevents/events/.
About Calyxt
Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. By combining its leading gene-editing technology and technical expertise with its innovative commercial strategy, Calyxt is pioneering a paradigm shift to deliver healthier food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance, for farmers. Calyxt is located in Minneapolis-St. Paul, Minn., and is listed on the Nasdaq market (ticker: CLXT).
For further information please visit our website: www.calyxt.com.
Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170925006416/en/
For Calyxt
Media
Jennifer Moore, 917-580-1088
VP
Communications
media@calyxt.com
or
KCSA
Strategic Communications
Caitlin Kasunich, 212-896-1241
ckasunich@kcsa.com
or
Nick
Opich, 212-896-1206
nopich@kcsa.com
or
Investor
Relations
Simon Harnest, 646-385-9008
VP Corporate
Strategy and Finance
simon.harnest@cellectis.com